Funding

We’d like to express our gratitude to our funding partners, past and present.

Tourette-related funding (Black lab and collaborators)

Current:

NIH

  • R01 MH118217 – Longitudinal study of brain imaging and cognitive markers of Tourette syndrome in children
  • R01 MH104030 – The New Tics Study: A Novel Approach to Pathophysiology and Cause of Tic Disorders

The Washington University Institute of Clinical and Translational Sciences (supported by NIH CTSA grant UL1TR002345)

  • Peripheral induction of inhibitory brain circuits to treat Tourette’s: pilot

Emalex Biosciences

  • Multi-site treatment studies in TS

Past:

NIH

  • R21 MH091512 – LONGITUDINAL EFFECTS OF TREATMENT ON BRAIN FUNCTION IN CHILDREN WITH TOURETTE SYN
  • K24 MH087913 – Training Investigators in Neuroimaging and Neuropsychiatry of Movement Disorders; Training New Investigators in Neuroimaging and in the Neuropsychiatry of Movement
  • R01 MH073856 – Dopaminergic Effects on Cortical Function in Tourette’s
  • R13 NS066788 – 5th International Scientific Symposium on Tourette Syndrome
  • R21 MH098670 – TESTING THE PHASIC DOPAMINE RELEASE HYPOTHESIS IN TOURETTE SYNDROME: PILOT
  • P30 HD062171 – Washington University Intellectual and Developmental Disabilities Research Center
  • K01 MH104592 – PREDICTING OUTCOME IN CHILDREN WITH TIC DISORDERS USING NEUROIMAGING DATA
  • R21 NS091635 – PREDICTING OUTCOME IN CHILDREN WITH NEW-ONSET TICS USING NEUROIMAGING DATA
  • U54 HD087011 – Washington University Intellectual and Developmental Disabilities Research Center
  • F32 NS065649 – Medication-Induced Changes in Brain Function in Children with Tourette Syndrome

Tourette Association of America

  • 1998-1999       PET studies with NMB in Tourette Syndrome
  • 2000-2001       A pilot study of levodopa for treatment of tics in children and adults
  • 2003-2004       Levodopa-stimulated dopamine release (pilot)
  • 2004-2005       Morphological abnormalities of the thalamus and basal ganglia in Tourette syndrome by computational anatomy (PI: L. Wang)
  • 2005-2006       Levodopa-stimulated dopamine release II
  • 2008-2009       Finding tics in the community without putting a doctor on every corner
  • 2010-2011       Uncovering disparities in TS prevalence and identification between Caucasians and African-Americans (PI: C. Striley)
  • 2010-2012       Tourette Syndrome Association neuroimaging consortium pilot
  • 2015-2017       Network Architecture of the Brain in Tourette Syndrome and its Phenotypic Subgroups
  • 2015-2017       Prevalence of TD and Tics among a Community-recruited Sample of Adults from Haiti (PI: C. Striley)
  • 2015-2018       Testing a Pathophysiological Model of Complex Tics (PI: C. Richards)
  • 2019      Tic Talk 2019
  • 2020     Tic Talk 2020 (TAA-CDC Small Grants Program)

NARSAD

  • 1999-2001         Levodopa activation fMRI study of Tourette syndrome

McDonnell Center for Systems Neuroscience at Washington University

  • 2014-2015        A new collaboration with Abby Hollander, M.D.
  • 2017                   BIGTIC collaboration meeting
  • 2019                  TicTalk 2019

Neurocrine Biosciences, Inc., Psyadon Pharmaceuticals

  • Multi-site treatment studies in TS